• Capturing Pre-Commercial-$tage Value

    Welcome to Life Science Deal Flow. Our aim here is to hold my mouse to the fire by documenting the winners (and losers) of my life science trades and strategies. The focus is on a unique opportunities presented by pre-commercial stage life science entities. Don't forget to visit and subscribe to my other site, a FREE Venture Capital and competitive intelligence dBase, OnBioVC.
  • SEARCH the Life Science Deal Flow ARCHIVE

  • business strategy life science

But before you attend BioBeers be certain to attend the Colorado Bioscience Association BioBoulder Networking Reception 5:30 – 7:00 at Rembrandt Yard. More info (HERE). Then just when you think it is time to head home for dinner, enjoy a summer evening with the family and walk the dog beware, because it is actually time [...]

An unfortunate day indeed as Replidyne (NASDAQ: RDYN) has terminated their licensing deal with Asubio Pharma for its lead drug candidate Faropenem and subsequently is expecting a charge of approximately $4.1M. Recall, Replidyne discontinued enrollment in a late-stage study testing its faropenem medoxomil oral antibiotic as a treatment for patients with acute chronic bronchitis due [...]

  

to top of page...


 
  • Search the LSDF Archive

  • Your Advert Can Go Here!

    Find out how, email: arubenstein@rnaventures.com